Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $11.73 billion. The enterprise value is $10.14 billion.
| Market Cap | 11.73B |
| Enterprise Value | 10.14B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 272.71 million shares outstanding. The number of shares has decreased by -7.74% in one year.
| Current Share Class | 272.71M |
| Shares Outstanding | 272.71M |
| Shares Change (YoY) | -7.74% |
| Shares Change (QoQ) | -1.83% |
| Owned by Insiders (%) | 2.46% |
| Owned by Institutions (%) | 81.48% |
| Float | 232.28M |
Valuation Ratios
The trailing PE ratio is 19.53 and the forward PE ratio is 18.22. Exelixis's PEG ratio is 0.77.
| PE Ratio | 19.53 |
| Forward PE | 18.22 |
| PS Ratio | 5.24 |
| Forward PS | 5.00 |
| PB Ratio | 5.47 |
| P/TBV Ratio | 5.61 |
| P/FCF Ratio | 14.13 |
| P/OCF Ratio | 13.77 |
| PEG Ratio | 0.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.01, with an EV/FCF ratio of 12.35.
| EV / Earnings | 15.75 |
| EV / Sales | 4.41 |
| EV / EBITDA | 12.01 |
| EV / EBIT | 12.45 |
| EV / FCF | 12.35 |
Financial Position
The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.50 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.23 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 30.22% and return on invested capital (ROIC) is 21.91%.
| Return on Equity (ROE) | 30.22% |
| Return on Assets (ROA) | 18.05% |
| Return on Invested Capital (ROIC) | 21.91% |
| Return on Capital Employed (ROCE) | 33.41% |
| Revenue Per Employee | $2.00M |
| Profits Per Employee | $561,086 |
| Employee Count | 1,147 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.23 |
Taxes
In the past 12 months, Exelixis has paid $194.50 million in taxes.
| Income Tax | 194.50M |
| Effective Tax Rate | 23.21% |
Stock Price Statistics
The stock price has increased by +95.95% in the last 52 weeks. The beta is 0.29, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +95.95% |
| 50-Day Moving Average | 39.01 |
| 200-Day Moving Average | 34.07 |
| Relative Strength Index (RSI) | 59.04 |
| Average Volume (20 Days) | 3,880,227 |
Short Selling Information
The latest short interest is 18.72 million, so 6.87% of the outstanding shares have been sold short.
| Short Interest | 18.72M |
| Short Previous Month | 19.18M |
| Short % of Shares Out | 6.87% |
| Short % of Float | 8.06% |
| Short Ratio (days to cover) | 5.84 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.30 billion and earned $643.57 million in profits. Earnings per share was $2.20.
| Revenue | 2.30B |
| Gross Profit | 2.22B |
| Operating Income | 814.51M |
| Pretax Income | 450.97M |
| Net Income | 643.57M |
| EBITDA | 844.28M |
| EBIT | 814.51M |
| Earnings Per Share (EPS) | $2.20 |
Balance Sheet
The company has $1.03 billion in cash and $187.13 million in debt, giving a net cash position of $1.46 billion or $5.37 per share.
| Cash & Cash Equivalents | 1.03B |
| Total Debt | 187.13M |
| Net Cash | 1.46B |
| Net Cash Per Share | $5.37 |
| Equity (Book Value) | 2.13B |
| Book Value Per Share | 7.75 |
| Working Capital | 997.40M |
Cash Flow
In the last 12 months, operating cash flow was $842.59 million and capital expenditures -$21.70 million, giving a free cash flow of $820.89 million.
| Operating Cash Flow | 842.59M |
| Capital Expenditures | -21.70M |
| Free Cash Flow | 820.89M |
| FCF Per Share | $3.01 |
Margins
Gross margin is 96.78%, with operating and profit margins of 35.43% and 27.99%.
| Gross Margin | 96.78% |
| Operating Margin | 35.43% |
| Pretax Margin | 36.45% |
| Profit Margin | 27.99% |
| EBITDA Margin | 36.73% |
| EBIT Margin | 35.43% |
| FCF Margin | 35.71% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.74% |
| Shareholder Yield | 7.74% |
| Earnings Yield | 5.55% |
| FCF Yield | 7.08% |
Analyst Forecast
The average price target for Exelixis is $39.18, which is -8.95% lower than the current price. The consensus rating is "Buy".
| Price Target | $39.18 |
| Price Target Difference | -8.95% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 11.08% |
| EPS Growth Forecast (5Y) | 25.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 9.09 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.09 |
| Piotroski F-Score | 7 |